PetCure Oncology and Nanovi Announce PetXmark™ Partnership to Introduce Fiducial Guided Stereotactic Radiotherapy for Pet Patients with Cancers
07. Dezember 2017 10:00 ET
|
PetCure Oncology
Chicago, IL and Copenhagen, Denmark, Dec. 07, 2017 (GLOBE NEWSWIRE) -- PetCure Oncology Inc. (PetCure) and Nanovi A/S (Nanovi) announced an exclusive agreement to use PetXmark™ in the development...